Form 4: enVVeno Medical Corp Executive Hamed Alavi Executes Option and Sells Shares
SEC Form 4 Filing
Chief Technology Officer of enVVeno Medical Corp, Hamed Alavi, exercised stock options and sold the acquired shares on March 13, 2024.
Summary
- Hamed Alavi, Chief Technology Officer of enVVeno Medical Corp, filed a Form 4.
- On March 13, 2024, Alavi exercised stock options to acquire 8,334 shares of common stock at a price of $3.59 per share.
- On the same day, Alavi sold 8,334 shares of common stock at a price of $6.22 per share.
- Following the transaction, Alavi directly owns 91,666 stock options.
Sentiment
Score: 5
Explanation: The document is a neutral report of stock transactions. There is no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives. It is common for executives to exercise stock options and sell shares for personal financial management.
Key Dates
| Date | Description |
|---|---|
| 12/05/2023 | Stock options were issued to Hamed Alavi pursuant to the Amended and Restated 2016 Omnibus Incentive Plan. |
| 03/13/2024 | Hamed Alavi exercised stock options and sold shares. |
| 03/15/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.